Literature DB >> 31614058

Failure of atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients.

Teresa A Chueng1, Ilona V Moroz2, Anthony D Anderson3, Michele I Morris2, Krishna V Komanduri4, Jose F Camargo2.   

Abstract

Entities:  

Keywords:  prophylaxis; stem cell transplant; toxoplasmosis

Year:  2019        PMID： 31614058     DOI： 10.1111/tid.13198

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN： 1398-2273            Impact factor:   2.228


× No keyword cloud information.
  2 in total

1.  Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.

Authors:  Ruth O Adekunle; Amy Sherman; Jennifer O Spicer; Julia A Messina; Julie M Steinbrink; Mary Elizabeth Sexton; George Marshall Lyon; Aneesh K Mehta; Varun K Phadke; Michael H Woodworth
Journal:  Transpl Infect Dis       Date:  2021-06-01

2.  Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling.

Authors:  Maguy Hamie; Rania Najm; Carine Deleuze-Masquefa; Pierre Antoine Bonnet; Jean-François Dubremetz; Marwan El Sabban; Hiba El Hajj
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.